We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.78B
AUM Growth
-$185M
Cap. Flow
-$20.5M
Cap. Flow %
-0.74%
Top 10 Hldgs %
20.31%
Holding
3,133
New
26
Increased
312
Reduced
483
Closed
54

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$3.61M
2
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$3.51M
3
SRLN icon
State Street Blackstone Senior Loan ETF
SRLN
+$2.84M
4
PWR icon
Quanta Services
PWR
+$2.44M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.13M

Top Sells

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$4.58M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$4.54M
3
CONE
CyrusOne Inc Common Stock
CONE
+$4.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.09M
5
IVE icon
iShares S&P 500 Value ETF
IVE
+$3.23M

Sector Composition

Rank Sector Weight
1 Technology 18.27%
2 Consumer Discretionary 10.26%
3 Financials 9.82%
4 Industrials 9.34%
5 Healthcare 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACWI icon
3026
iShares MSCI ACWI ETF
ACWI
$33.6B
$2K ﹤0.01%
20
– –
APLT
3027
DELISTED
Applied Therapeutics
APLT
$2K ﹤0.01%
1,179
– –
BDSX icon
3028
Biodesix
BDSX
$261M
$2K ﹤0.01%
48
– –
CDZI icon
3029
Cadiz
CDZI
$302M
$2K ﹤0.01%
1,074
– –
ETNB
3030
DELISTED
89bio
ETNB
$2K ﹤0.01%
560
– –
HOOK
3031
DELISTED
HOOKIPA Pharma
HOOK
$2K ﹤0.01%
86
– –
IRON icon
3032
Disc Medicine
IRON
$3.05B
$2K ﹤0.01%
57
– –
KLTR icon
3033
Kaltura
KLTR
$243M
$2K ﹤0.01%
1,335
– –
PBE icon
3034
Invesco Biotechnology & Genome ETF
PBE
$360M
$2K ﹤0.01%
45
– –
RFL icon
3035
Rafael Holdings
RFL
$107M
$2K ﹤0.01%
781
– –
SHEL icon
3036
Shell
SHEL
$248B
$2K ﹤0.01%
+44
New +$2.34K
TERN
3037
DELISTED
Terns Pharmaceuticals
TERN
$2K ﹤0.01%
708
– –
WEAV icon
3038
Weave Communications
WEAV
$401M
$2K ﹤0.01%
361
– –
TLIS
3039
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$2K ﹤0.01%
72
– –
CYT
3040
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$2K ﹤0.01%
641
– –
HMPT
3041
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$2K ﹤0.01%
600
– –
ISO
3042
DELISTED
IsoPlexis Corporation Common Stock
ISO
$2K ﹤0.01%
650
– –
NH
3043
DELISTED
NantHealth, Inc
NH
$2K ﹤0.01%
159
– –
KLDO
3044
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$2K ﹤0.01%
995
– –
AVTX icon
3045
Avalo Therapeutics
AVTX
$1.04B
$1K ﹤0.01%
1
– –
CGAU
3046
Centerra Gold
CGAU
$4.15B
$1K ﹤0.01%
+106
New +$950
FBRX icon
3047
Forte Biosciences
FBRX
$1.57B
$1K ﹤0.01%
35
– –
LSF icon
3048
Laird Superfood
LSF
$47.3M
$1K ﹤0.01%
261
– –
LUCD icon
3049
Lucid Diagnostics
LUCD
$185M
$1K ﹤0.01%
390
– –
OTRK
3050
DELISTED
Ontrak
OTRK
$1K ﹤0.01%
7
– –
120 121
122
123 124

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Ameritas Investment Partners held 3,133 positions worth $2.78B, down 6.2% from $2.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 2.6%. Ameritas Investment Partners opened 26 new positions and exited 54, leaving the 3,133-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ameritas Investment Partners's largest Q1 2022 buy was Bank of America Series L: 2,589 shares worth $3.4M.
  • Ameritas Investment Partners added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2022, an estimated $3.61M increase.
  • Ameritas Investment Partners's biggest Q1 2022 reduction was Molina Healthcare, cutting an estimated $4.58M.
  • Ameritas Investment Partners fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $4.1M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.78B portfolio in Q1 2022.
  • Ameritas Investment Partners opened 26 new positions and closed 54 in Q1 2022.
  • Ameritas Investment Partners's portfolio value fell 6.2% quarter-over-quarter to $2.78B.

Based on Ameritas Investment Partners's 13F filing for Q1 2022, filed 13 May 2022.